Find a Provider

Patient Results

Real Patients.
Noticeable Results.

Don’t take our word for it. Check out these patients who have experienced the ellacor difference.

A Procedure Worth Talking About.

Hear from real patients about the results they experienced for themselves.

I loved my ellacor results. I was looking to get a little something more from a treatment, but wasn’t ready for surgery and ellacor delivered exactly what I had in mind.

ellacor® patient

I was pleasantly surprised to find that I experienced a slight lift on my upper lip that gave the appearance of extra volume. (Win-win!) And though true results wouldn’t appear for a couple months, I was already noticing a slight tightening of the folds around my mouth.

Hannah @softblond
Editor at PopSugar

That’s exactly the skin that I used to have when I was in my early 20’s, and now I have this beautiful young-looking skin again.

Liana M.
ellacor® patient

I am very happy with the entire process – from treatment to healing time, to the results. I would highly recommend this treatment to anyone.

A community member

I noticed a change in my skin after just one treatment, and after my third session, I felt like my skin was just so refreshed and brought back to life. Ellacor really gave me a newfound confidence in myself.

ellacor® patient

Treatments like ellacor are changing the game for those of us who want nonsurgical options to feel good in our skin — which, after my treatment, I can honestly say I do.

Hannah @softblond
Editor at PopSugar

People are telling me now that I look 7-10 years younger just after [my] 1st Ellacor treatment. I cannot wait the results after my 2nd Ellacor treatment.

Liana M.
ellacor® patient
Ellacor woman photo with smile

Are You Ready to Reveal Your Inner Youth?

Click below to schedule a consultation with an ellacor provider near you.

Find a Provider


The ellacor® System with Micro-Coring® technology is indicated for use by medical professionals for the treatment of moderate and severe wrinkles in the mid and lower face in adults aged 22 years or older with Fitzpatrick skin types I-IV.

Important Safety Information


Your medical professional will discuss the following side effects with you prior to treatment. Proper pre- and post-treatment care reduces the risk of these side effects; however, some conditions may or may not resolve over time. Side effects associated with this procedure may include: redness, swelling, bruising, burning, dryness, roughness, tightness/pulling of skin, crusting, pain/discomfort, tenderness, tingling, bleeding, numbness, skin peeling, or circular marks on skin.

Other side effects not commonly observed with this procedure may include: itching, hyper/hypo pigmentation, hematoma, infection, scarring, skin irregularities, skin necrosis, uneven appearance of the treated regions (left and right sides of face), or anesthesia toxicity (anesthesia-related complications may include allergic reaction and possibly death).


The ellacor® procedure should not be used for the treatment of areas of skin with dermatosis (e.g. skin tumors, keloids or in case of predisposition to keloids, solar keratosis, warts, or birthmarks), area within the bony orbital rim; mucous membranes; areas where silicone or synthetic material is implanted.
The ellacor® procedure should not be used on patients that are pregnant or nursing mothers, suffering from open wounds, sores, or irritated skin in the treatment area, have an allergy to stainless steel or allergy to topical, oral, or injected medications or preparations that may be used during the procedure, such as petrolatum, lidocaine, bupivacaine, chlorhexidine, or povidone-iodine. Patients that have a history or presence of any clinically significant bleeding disorder, have dermatological or autoimmune conditions that may affect the treatment outcome; these may include, but are not limited to: actinic keratosis, raised nevi, rosacea, melasma, active acne, cutaneous papules/nodules, active inflammatory lesions, dermatitis, psoriasis, cellulitis, urticarial folliculitis, acute inflammatory phase of scleroderma, rheumatoid arthritis, eczema, psoriasis, allergic dermatitis, collagen disorders, or lupus should not be treated with the ellacor® procedure. Additionally, patients that have systemic infections or acute local skin infections such as Hepatitis disorders type A, B, C, D, E or F or HIV infection, take a high dose of anti-coagulants or blood-thinning substances (e.g. aspirin, nonsteroidal anti-inflammatory drugs, NSAIDs, warfarin, heparin, acetylsalicylic acid during the previous fourteen (14) days), are on courses of chemotherapy, high-dose corticosteroid use, or radiation in the treatment area, have undergone plastic surgery of the face within the last twelve (12) months or have any facial surgical scars less than twelve (12) months old, have undergone injections of dermal fillers, fat, or botulinum toxin, as well as any minimally invasive/invasive skin treatment in the treatment area during the previous six (6) months, or have scars less than six (6) months old in the treatment area should not be treated with the ellacor® procedure.


Appropriateness for treatment is based on the clinical assessment of the patient by the treating physician. Use caution when treating patients with the following conditions or taking the following medications:

  • History of hyperpigmentation
  • Recent exposure to sun or tanning beds with red, peeling, or swollen skin
  • Active, chronic, or recurrent infection including bacterial or fungal infections
  • History of active herpes simplex infection in the treatment area
  • Use of topical or oral preparations/medications that may change the skin integrity or prolong healing
  • Over the Counter (OTC) and herbal supplements that may increase the risk of bleeding or prolong healing, such as gingko biloba, garlic, ginseng, dong quai, fever few, and fish oil
  • Other medications or medical conditions that may interfere with the treatment or that the treatment provider believes may compromise the safety of the patient or the efficacy of the treatments. Refer the patient to their Primary Care Physician (PCP) or other managing health care provider or clearance prior to treatment
  • Recent trauma or surgery to the treatment area